Summit Therapeutics
SMMT
#1617
Rank
ยฃ9.47 B
Marketcap
ยฃ12.73
Share price
0.18%
Change (1 day)
-12.85%
Change (1 year)

Revenue for Summit Therapeutics (SMMT)

Revenue in 2019 (TTM): ยฃ1.12 Million

a decrease over the revenue in the year 2018 that were of ยฃ58.44 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Summit Therapeutics from 2018 to 2019

Annual revenue

Year Revenue Change
2019 ยฃ1.12 M-98.08%
2018 ยฃ58.44 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
ยฃ1.80 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
ยฃ0.27 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
ยฃ62.44 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA